AKCEA THERAPEUTICS INC's ticker is AKCA and the CUSIP is 00972L107. A total of 65 filers reported holding AKCEA THERAPEUTICS INC in Q4 2018. The put-call ratio across all filers is 1.07 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2018 | $251,000 | – | 7,170 | – | 0.14% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Bellevue Group AG | 3,162,643 | $53,575,000 | 0.85% |
| INTERNATIONAL BIOTECHNOLOGY TRUST PLC | 31,723 | $536,000 | 0.19% |
| Amia Capital LLP | 28,217 | $478,000 | 0.14% |
| Motley Fool Asset Management LLC | 60,489 | $1,025,000 | 0.11% |
| Virtus ETF Advisers LLC | 33,059 | $560,000 | 0.09% |
| ALTRINSIC GLOBAL ADVISORS LLC | 70,286 | $1,191,000 | 0.05% |
| A.R.T. Advisors, LLC | 53,560 | $907,000 | 0.04% |
| TUDOR INVESTMENT CORP ET AL | 46,433 | $787,000 | 0.04% |
| Caption Management, LLC | 54,000 | $915,000 | 0.03% |
| Caption Management, LLC | 54,000 | $915,000 | 0.03% |